Long-Term Follow-Up of Patients Undergoing Catheter Ablation

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2011 by University of Oklahoma
Sponsor:
Information provided by:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT00584558
First received: December 20, 2007
Last updated: March 2, 2011
Last verified: March 2011
  Purpose

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at the OU Medical Center.


Condition Intervention
Arrhythmia
Procedure: Catheter Ablation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Long-Term Follow-Up of Patients Undergoing Catheter Ablation

Resource links provided by NLM:


Further study details as provided by University of Oklahoma:

Primary Outcome Measures:
  • Arrhythmia recurrence [ Time Frame: 0-10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Complications [ Time Frame: 0-10 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 5000
Study Start Date: December 2000
Estimated Study Completion Date: November 2050
Estimated Primary Completion Date: November 2050 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Patients undergoing catheter ablation.
Procedure: Catheter Ablation
Catheter Ablation of arrhythmias
Other Names:
  • All approved ablation catheters
  • Investigational ablation catheters

Detailed Description:

The purpose of this study is to assess the long-term effects of catheter ablation procedures performed at this institution, including recurrence of the ablated arrhythmia and any late complications.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients undergoing catheter ablation at the OU Medical Center

Criteria

Inclusion Criteria:

  • Undergoing catheter ablation at the OU Medical Center

Exclusion Criteria:

  • Prisoners
  • Refusal to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00584558

Contacts
Contact: Karen Beckman, MD 405-271-9696 ext 37536 Karen-Beckman@ouhsc.edu

Locations
United States, Oklahoma
OU Medical Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Principal Investigator: Karen Beckman, MD         
Sponsors and Collaborators
University of Oklahoma
Investigators
Principal Investigator: Karen Beckman, MD University of Oklahoma
  More Information

No publications provided

Responsible Party: Karen Beckman, M.D., University of Oklahoma Health Science Center
ClinicalTrials.gov Identifier: NCT00584558     History of Changes
Other Study ID Numbers: 09343
Study First Received: December 20, 2007
Last Updated: March 2, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Oklahoma:
Arrhythmia
Catheter Ablation

Additional relevant MeSH terms:
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on July 20, 2014